Elisa Pérez-Moreno

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

L. Carvajal-Carmona, M. Camus, P. Carvallo, 2017, Oncotarget.

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

L. Carvajal-Carmona, M. Camus, P. Carvallo, 2017, Oncotarget.

miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival.

M. Camus, P. Carvallo, Teresa Tapia, 2016, Cancer biomarkers : section A of Disease markers.

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

L. Carvajal-Carmona, M. Camus, P. Carvallo, 2017, Oncotarget.

Novel microRNAs downregulated in breast cancer tumors bind to the 3’UTR of SNAIL, SLUG, ZEB1 and/or TWIST and decrease metastatic behavior in breast cancer cells

P. Carvallo, Wanda Fernández, Valentina A. Zavala, 2023, bioRxiv.